Abstract:The development of peptide drugs has made tremendous progress in the past few decades because of the advancements in modification chemistry and analytical technologies. The novel‐designed peptide drugs have been modified through various biochemical methods with improved diagnostic, therapeutic, and drug‐delivery strategies. Researchers found it a helping hand to overcome the inherent limitations of peptides and bring continued advancements in their applications. Furthermore, the emergence of peptide‐drug conjugates (PDCs)—utilizes target‐oriented peptide moieties as a vehicle for cytotoxic payloads via conjugation with cleavable chemical agents, resulting in the key foundation of the new era of targeted peptide drugs. This review summarizes the various classifications of peptide drugs, suitable chemical modification strategies to improve the ADME (adsorption, distribution, metabolism, and excretion) features of peptide drugs, and recent (2015–early 2024) progress/achievements in peptide‐based drug delivery systems as well as their fruitful implication in preclinical and clinical studies. Furthermore, we also summarized the brief description of other types of PDCs, including peptide‐MOF conjugates and peptide‐UCNP conjugates. The principal aim is to provide scattered and diversified knowledge in one place and to help researchers understand the pinching knots in the science of PDC development and progress toward a bright future of novel peptide drugs.

Auto‐Cleaving Bond for Better Drugs

Mechanochemical bond scission for the activation of drugs

New peptide deformylase inhibitors design, synthesis and pharmacokinetic assessment

Unleashing the Power of Bond Cleavage Chemistry in Living Systems

Recent Advances in the Linkers of Drug Conjugates

Gold(III)-Induced Amide Bond Cleavage In Vivo: A Dual Release Strategy via π-Acid Mediated Allyl Substitution

Molecular glue-mediated targeted protein degradation: A novel strategy in small-molecule drug development

Dendrimer-Based Prodrugs: Design, Synthesis, Screening And Biological Evaluation

Supramolecular Amphiphiles Based on Cyclodextrin and Hydrophobic Drugs

The Disulfide Bond-Mediated Cyclization of Oral Peptides

Overcoming the shortcomings of peptide-based therapeutics

Peptide-Drug Conjugate: A Novel Drug Design Approach

Strategies to prepare polymers with cleavable linkages releasing active agents in acidic media

Biocompatible Strategies for Peptide Macrocyclisation

Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors

Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

Bivalent Ligands for Protein Degradation in Drug Discovery

Peptide therapeutics: Targeting the undruggable space

Rethinking amide bond synthesis

Merging the Versatile Functionalities of Boronic Acid with Peptides

Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic